HughBrentSolvasonMD
Psychiatry • Palo Alto, CAAssociate Professor, Psychiatry & Behavioral Science, Stanford University Medical Center
Dr. Solvason is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 Quarry Rd Rm 2138
Department Of Psychiatry
Palo Alto, CA 94304Phone+1 650-776-4793Fax+1 650-723-8331- Is this information wrong?
Summary
- The treatment of severe treatment resistant/refractory depression using brain stimulation technologies with clinical and research experience with TMS, iTBS, accelerated iTBS, VNS. I have 20 years experience doing ECT. Also an interest in novel pharmacotherapies for treatment resistant depression including ketamine nasal spray and infusion and lithium for treatment resistant depression.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityResidency, Psychiatry, 1993 - 1997
University of Alabama School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1995 - 2024- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011, 2013
Clinical Trials
- Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression Start of enrollment: 2003 May 01
- Memantine to Reduce Neurocognitive Deficits Following Unilateral ECT for the Treatment of a Major Depression Start of enrollment: 2004 Feb 01
- Mifepristone Treatment for Patients With Non-psychotic Major Depressive Disorder Receiving Bilateral ECT Start of enrollment: 2003 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 165 citationsStanford Accelerated Intelligent Neuromodulation Therapy for Treatment-Resistant DepressionE. Cole, Katy H. Stimpson, Brandon S. Bentzley, M. Gulser, Kirsten Cherian, Claudia Tischler, Romina Nejad, Heather Pankow, Elizabeth Choi, Haley Aaron, Flint M. Espil...> ;The American Journal of Psychiatry. 2020 Apr 7
- 24 citationsTranscranial magnetic stimulation (TMS) for major depression: a multisite, naturalistic, observational study of quality of life outcome measures in clinical practicePhilip G. Janicak, David L. Dunner, Scott Aaronson, Linda L. Carpenter, Terrence Boyadjis, David G. Brock, Ian A. Cook, Karl Lanocha, Hugh B. Solvason, Dafna Bonneh-Ba...> ;CNS Spectrums. 2013 Dec 1
- Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-mo...Janicak PG, Nahas Z, Lisanby SH, Solvason HB, Sampson SM, McDonald WM, Marangell LB, Rosenquist P, McCall WV, Kimball J, O'Reardon JP, Loo C, Husain MH, Krystal A, Gil...> ;Brain Stimul. 2010-10-01
- Join now to see all
Hospital Affiliations
Stanford Health CarePalo Alto, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
